Westward Independent

Infants act meets Fentora

by Westward Independent
1 comment

 

The B.C. Infants Act (BCIA), works similarly to others such as some Mature/Minor Acts, however, the BCIA has no minimum age requirement for consent: Part 2 — Medical Treatment — “Consent of infant to medical treatment: 17 (1). “health care” means anything that is done for therapeutic, preventive, palliative, diagnostic, cosmetic or other health-related purposes, and includes a course of health care; (2) Subject to subsection (3), an infant may consent to health care whether or not that health care would, in the absence of consent, constitute a trespass to the infant’s person, and if an infant provides that consent, the consent is effective and it is not necessary to obtain a consent to the health care from the infant’s parent or guardian.”


There are many stories over the years from parents whose children were inoculated in the schools without parental permission and subsequently had reactions. A mother who tried to fight this Act after her son was injured playing sports, and was prescribed opioids by the doctor without her knowledge, only to have him later die from an overdose. Then there is a father who for years fought to keep his pre-pubescent child from medically transitioning, had his hands tied due to this Act. The latest worry from parents is the introduction, brought in last August, of Minors into the Provincial “Safe Supply” program by the British Columbia Centre on Substance Use (BCCSU).


“FENTORA is an opioid with no approved use in the management of addictive disorders. Its proper usage in individuals with drug or alcohol dependence, either active or in remission, is for the management of breakthrough cancer pain requiring opioid analgesia” (product monograph)
“Pediatrics (< 18 years of age): The safety and efficacy of FENTORA have not been studied in the pediatric population. Therefore, use of FENTORA is not recommended in patients under 18 years of age.” (product monograph)


The taxpayer-funded “safe supply” program uses fentanyl tablets, brand name FENTORA, which states at least 6 times in their product monograph is NOT to be used for anyone under the age of 18 (“The safety and efficacy of FENTORA has not been studied in the pediatric population, and that it is only to be used for breakthrough pain in cancer patients that already have an opioid tolerance”).


FENTORA, a drug only for use with cancer patients, states it is not to be used even post-cancer treatment for pain, and that the pain management protocol for a cancer patient, already tolerant to opioids, must be given a 100 mcg dose, a maximum of 4 hours apart if there is breakthrough pain to a maximum dose of 800 mcgs. Why then, when looking at the protocols set out by the BCCSU, does it suggest 600-800 mcg treatments at three-hour intervals to begin with? The safe supply protocol has clients start at a 600 mcg dose, who are monitored and can be given the dose three hours apart. The dose can be increased 100 mcgs until the client is titrated, or is stopped at the dose level if the client experiences sedation.


FENTORA (fentanyl buccal/sublingual effervescent tablets) is intended to be used only in the care of opioid tolerant patients with cancer and only by healthcare professionals who are knowledgeable of, and skilled in, the use of opioids to treat cancer pain.


After the client shows tolerance over 4 doses over four days they are eligible to take the drugs home (after meeting some criteria) and then can have a one-year supply paid for by Pharmacare. In the protocol sheet for clients who are eligible to take the drugs off-site, it is stated that they must know how to treat and overdose, and are supplied with Naloxone, even though the product monograph states that Naloxone will cause ‘withdrawal symptoms”, which can be extremely severe.


Some of the protocols in the “safe supply” maintenance program are upwards of 2000 mcgs a day, completely ignoring the product’s very strict instructions for use. Additionally, there are lengthy protocols for clients who have gone to jail, detoxed, or been off the medication for 30+ days to start them back on at the base protocol of 600 mcgs all over again, as opposed to suggesting rehabilitation, or other avenues after obviously detoxing from this drug.
Even though FENTORA is very clear for whom it may be used: “FENTORA is indicated only for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant to continuous opioid therapy for their persistent baseline cancer pain. Patients considered opioid tolerant are those who are taking at least 60 mg of oral morphine daily or an equianalgesic dose of another opioid daily for a week or longer, the criteria for being accepted into the “safe supply” program is far more lax. Some of the criteria listed: “There may be some individuals who have not been diagnosed with an OUD (Opioid Use Dependence), who use unregulated fentanyl and would benefit from accessing prescribed safer supply. It is not a requirement for individuals to have trialled OAT (Opioid Agonist Treatment — uses medications such as Suboxone and Methadone to treat opioid addiction through oral and/or injection) to be considered. Co-morbid mental and physical health conditions. Prescribed and non-prescribed medication(s) and natural health products”.


The FENTORA product monograph is extremely clear on the extreme side effects, with a multitude of contraindications, which are, in essence, every usage beyond cancer pain. As well, FENTORA has 53 pages filled with dire warnings around any off-label usage — warnings that interactions with substances as simple as alcohol can be fatal, and long-term usage warnings that include: “Long-term use of opioids may be associated with decreased sex hormone levels and symptoms such as low libido, erectile dysfunction, or infertility.”


Why is a product tested for side effects on dogs, mice and rats, that is extremely transparent around proper usage, being paid for by taxpayers to be trialed off-label in our Province? Minors under 18 years of age should never be included in such a trial, ever. We see safe snorting kits, and safe crack handling protocol handouts being distributed in our schools across the nation. Why? And now this? The fact that your child could access this program without your knowledge is horrific. The Infants Act needs to be amended and updated now once and for all. – By Staff

You may also like

1 comment

Summer February 3, 2024 - 6:24 am

Excellent Article! Thank you. I did not have time to look up the infants act, this is terrifying. Another good reason to fire this government. S

Reply

Leave a Comment

As a dedicated grassroots newspaper, we unearth exclusive valley stories and events that remain hidden elsewhere. With passion and fearlessness, we expose what happens behind closed doors, giving you a sneak peek into the heart of our community. Experience the pulse of our valley like never before. Welcome to a newspaper that punches above its weight, where local voices come alive with every turn of the page.

©2024 All rights reserved. Designed and Developed by WWIND.